NON-SMALL CELL LUNG CANCER - CACHEXIA (NSCLC-C) Clinical Trials
6 clinical trials for NON-SMALL CELL LUNG CANCER - CACHEXIA (NSCLC-C) across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.
- ROSETTA LUNG-201: A RANDOMIZED, MULTICENTER, OPEN-LABEL PHASE 3 STUDY OF PUMITAMIG MONOTHERAPY COMPARED TO DURVALUMAB IN PARTICIPANTS WITH UNRESECTABLE STAGE III NSCLC WITHOUT PROGRESSION AFTER PLATINUM-BASED CONCURRENT CHEMORADIATION THERAPY — RECRUITING · PHASE3
- A PHASE 2B/3, RANDOMIZED, DOUBLE-BLIND STUDY TO INVESTIGATE THE EFFICACY, SAFETY,
AND TOLERABILITY OF PONSEGROMAB (PF-06946860) COMPARED WITH PLACEBO BOTH WITH BACKGROUND
FIRST-LINE CHEMOTHERAPY IN ADULT PARTICIPANTS WITH CACHEXIA AND METASTATIC PANCREATIC DUCTAL
ADENOCARCINOMA — RECRUITING · PHASE2
- A PHASE 3 RANDOMIZED OPEN-LABEL STUDY OF ADJUVANT PEMBROLIZUMAB WITH OR WITHOUT MK-2870 IN PARTICIPANTS WITH RESECTABLE STAGE II TO IIIB (N2) NSCLC NOT ACHIEVING PCR AFTER RECEIVING NEOADJUVANT PEMBROLIZUMAB WITH PLATINUM-BASED DOUBLET CHEMOTHERAPY FOLLOWED BY SURGERY — RECRUITING · PHASE3
- A PHASE III, RANDOMISED, OPEN-LABEL, MULTICENTRE, GLOBAL STUDY OF DATOPOTAMAB DERUXTECAN (DATO-DXD) IN COMBINATION WITH DURVALUMAB AND CARBOPLATIN VERSUS PEMBROLIZUMAB IN COMBINATION WITH PLATINUM-BASED CHEMOTHERAPY FOR THE FIRST-LINE TREATMENT OF PATIENTS WITH LOCALLY ADVANCED OR METASTATIC NSCLC WITHOUT ACTIONABLE GENOMIC ALTERATIONS (AVANZAR) — RECRUITING · PHASE3
- A PHASE 2A RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED MULTICENTER STUDY TO INVESTIGATE THE EFFICACY, SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF PONSEGROMAB IN PATIENTS WITH CANCER, CACHEXIA, AND ELEVATED LEVELS OF GDF-15, FOLLOWED BY AN OPTIONAL OPEN-LABEL TREATMENT PERIOD. — RECRUITING · PHASE2
- AN INTERVENTIONAL, PHASE 1 B, DOUBLE-BLIND, RANDOMIZED, SPONSOR-OPEN, 2-ARM STUDY TO INVESTIGATE THE EFFECT OF PONSEGROMAB ON SKELETAL MUSCLE MASS AND PHYSICAL FUNCTION IN ADULT PARTICIPANTS WITH NON-SMALL CELL LUNG CANCER-ASSOCIATED CACHEXIA — NOT_YET_RECRUITING · PHASE1
Refine this search